Osteocalcin and vitamin D status are inversely associated with homeostatic model assessment of insulin resistance in Canadian Aboriginal and white women: The First Nations Bone Health Study

Journal of Nutritional Biochemistry

Volumn 24, Issue 2, 2013, Pages 412-418

  Weiler, Hope A ^a   Lowe, Julie ^a   Krahn, John ^b   Leslie, William D ^c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Ethnicity; Glucose; Osteocalcin; Vitamin D

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; OSTEOCALCIN; VITAMIN D;

ABORIGINE; ADULT; ARTICLE; BODY MASS; CANADA; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSGLYCEMIA; ETHNICITY; FEMALE; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; TRUNK;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; BODY COMPOSITION; BODY MASS INDEX; C-PEPTIDE; CANADA; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; OSTEOCALCIN; VITAMIN D;

EID: 84872792904     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.12.007     Document Type: Article

References (52)

1. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130(3):456-469.
2. Fernandez-Real J.M., Izquierdo M., Ortega F., Gorostiaga E., Gomez-Ambrosi J., Moreno-Navarrete J.M., et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009, 94(1):237.
3. Spronk H.M., Soute B.A., Schurgers L.J., Cleutjens J.P., Thijssen H.H., De Mey J.G., et al. Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochem Biophys Res Commun 2001, 289(2):485-490.
4. Karner E., Backesjo C.M., Cedervall J., Sugars R.V., Ahrlund-Richter L., Wendel M. Dynamics of gene expression during bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Biochim Biophys Acta 2009, 1790(2):110-118.
5. Hwang Y.C., Jeong I.K., Ahn K.J., Chung H.Y. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev 2009, 25(8):768-772.
6. Iki M., Tamaki J., Fujita Y., Kouda K., Yura A., Kadowaki E., et al. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int 2011.
7. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Kurioka S., Yano S., et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009, 94(1):45-49.
8. Kindblom J.M., Ohlsson C., Ljunggren O., Karlsson M.K., Tivesten A., Smith U., et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009, 24(5):785-791.
9. Bao Y., Zhou M., Lu Z., Li H., Wang Y., Sun L., et al. Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men. Clin Endocrinol (Oxf) 2011.
10. Im J.A., Yu B.P., Jeon J.Y., Kim S.H. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 2008, 396(1-2):66-69.
11. Pittas A.G., Harris S.S., Stark P.C., Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007, 30(4):980-986.
12. Bao Y.Q., Zhou M., Zhou J., Lu W., Gao Y.C., Pan X.P., et al. Relationship between serum osteocalcin and glycaemic variability in Type 2 diabetes. Clin Exp Pharmacol Physiol 2011, 38(1):50-54.
13. Ferron M., McKee M.D., Levine R.L., Ducy P., Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2011.
14. Iglesias P., Arrieta F., Pinera M., Botella-Carretero J., Balsa J., Zamarron I., et al. Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and beta-cross laps in obese subjects with varying degrees of glucose tolerance. Clin Endocrinol (Oxf) 2011.
15. Kanazawa I., Yamaguchi T., Yamauchi M., Yamamoto M., Kurioka S., Yano S., et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 2011, 22(1):187-194.
16. Hadjidakis D., Tsagarakis S., Roboti C., Sfakianakis M., Iconomidou V., Raptis S.A., et al. Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?. Clin Endocrinol (Oxf) 2003, 58(1):72-77.
17. Lewis J.G., Borowski K.K., Shand B.I., George P.M., Scott R.S. Plasma sex hormone-binding globulin, corticosteroid-binding globulin, cortisol, and free cortisol levels in outpatients attending a lipid disorders clinic: a cross-sectional study of 1137 subjects. Horm Metab Res 2010, 42(4):274-279.
18. Chiodini I., Torlontano M., Scillitani A., Arosio M., Bacci S., Di Lembo S., et al. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol 2005, 153(6):837-844.
19. Sun X., Morris K.L., Zemel M.B. Role of calcitriol and cortisol on human adipocyte proliferation and oxidative and inflammatory stress: a microarray study. J Nutrigenet Nutrigenomics 2008, 1(1-2):30-48.
20. Bell N.H., Epstein S., Greene A., Shary J., Oexmann M.J., Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985, 76(1):370-373.
21. Xiao Y., Cui J., Shi Y.H., Sun J., Wang Z.P., Le G.W. Effects of duodenal redox status on calcium absorption and related genes expression in high-fat diet-fed mice. Nutrition 2010, 26(11-12):1188-1194.
22. Norman A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008, 88(2):491S-499S.
23. Kamycheva E., Jorde R., Figenschau Y., Haug E. Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. J Endocrinol Invest 2007, 30(2):126-132.
24. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27(12):2813-2818.
25. Borissova A.M., Tankova T., Kirilov G., Dakovska L., Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003, 57(4):258-261.
26. Chiu K.C., Chu A., Go V.L., Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79(5):820-825.
27. Weiler H.A., Leslie W.D., Bernstein C.N. Parathyroid hormone is predictive of low bone mass in Canadian Aboriginal and white women. Bone 2008, 42(3):498-504.
28. Leslie W.D., Weiler H.A., Nyomba B.L. Ethnic differences in adiposity and body composition: the First Nations Bone Health Study. Appl Physiol Nutr Metab 2007, 32(6):1065-1072.
29. Leslie W.D., Metge C.J., Weiler H.A., Doupe M., Wood Steiman P., O'Neil J.D. Bone density and bone area in Canadian Aboriginal women: the First Nations Bone Health Study. Osteoporos Int 2006.
30. Institute of Medicine Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride 1997, National Academy Press, Washington, DC.
31. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
32. Zhou M., Ma X., Li H., Pan X., Tang J., Gao Y., et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 2009, 161(5):723-729.
33. Kelly C., Booth G.L. Diabetes in Canadian women. BMC Womens Health 2004, 4(Suppl 1):S16.
34. Bhattacharyya O.K., Estey E.A., Cheng A.Y. Update on the Canadian Diabetes Association 2008 clinical practice guidelines. Can Fam Physician 2009, 55(1):39-43.
35. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl 1):S62-S69.
36. Confavreux C.B., Levine R.L., Karsenty G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 2009, 310(1-2):21-29.
37. Pedrazzoni M., Ciotti G., Pioli G., Girasole G., Davoli L., Palummeri E., et al. Osteocalcin levels in diabetic subjects. Calcif Tissue Int 1989, 45(6):331-336.
38. Pietschmann P., Schernthaner G., Woloszczuk W. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia 1988, 31(12):892-895.
39. Bouillon R. Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 1995, 80(4):1194-1202.
40. Rico H., Hernandez E.R., Cabranes J.A., Gomez-Castresana F. Suggestion of a deficient osteoblastic function in diabetes mellitus: the possible cause of osteopenia in diabetics. Calcif Tissue Int 1989, 45(2):71-73.
41. Oz S.G., Guven G.S., Kilicarslan A., Calik N., Beyazit Y., Sozen T. Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc 2006, 98(10):1598.
42. Rosato M.T., Schneider S.H., Shapses S.A. Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus. Calcif Tissue Int 1998, 63(2):107-111.
43. Sayinalp S., Gedik O., Koray Z. Increasing serum osteocalcin after glycemic control in diabetic men. Calcif Tissue Int 1995, 57(6):422-425.
44. Orwoll E., Riddle M., Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1994, 59(5):1083-1087.
45. Sandler S., Buschard K., Bendtzen K. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro. Immunol Lett 1994, 41(1):73-77.
46. Bland R., Markovic D., Hills C.E., Hughes S.V., Chan S.L., Squires P.E., et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004, 89-90(1-5):121-125.
47. Kajikawa M., Ishida H., Fujimoto S., Mukai E., Nishimura M., Fujita J., et al. An insulinotropic effect of vitamin D analog with increasing intracellular Ca2+ concentration in pancreatic beta-cells through nongenomic signal transduction. Endocrinology 1999, 140(10):4706-4712.
48. Sergeev I.N., Rhoten W.B. 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line. Endocrinology 1995, 136(7):2852-2861.
49. Blum M., Dolnikowski G., Seyoum E., Harris S.S., Booth S.L., Peterson J., et al. Vitamin D(3) in fat tissue. Endocrine 2008, 33(1):90-94.
50. von Hurst P.R., Stonehouse W., Matthys C., Conlon C., Kruger M.C., Coad J. Study protocol-metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D intervention. BMC Public Health 2008, 8:267.
51. Weiler H.A., Leslie W.D., Krahn J., Steiman P.W., Metge C.J. Canadian aboriginal women have a higher prevalence of vitamin d deficiency than non-aboriginal women despite similar dietary vitamin d intakes. J Nutr 2007, 137(2):461-465.
52. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005, 16(7):713-716.